Form 8-K - Current report:
SEC Accession No. 0001104659-21-128459
Filing Date
2021-10-21
Accepted
2021-10-21 16:15:55
Documents
12
Period of Report
2021-10-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2130784d1_8k.htm   iXBRL 8-K 22647
  Complete submission text file 0001104659-21-128459.txt   194097

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qure-20211021.xsd EX-101.SCH 3186
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20211021_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20211021_pre.xml EX-101.PRE 22711
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2130784d1_8k_htm.xml XML 3498
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 211337184
SIC: 2834 Pharmaceutical Preparations